Regionshospital Nordjylland — Clinical Trial Site

16 Registered trials

5 Currently recruiting

Organisation

Regionshospital Nordjylland

Location

Hjoerring, Denmark

Identifier

ORG-100041627

Address

Bispensgade 37, 9800, Denmark

Departments

7609:Department of Cardiology
Afdeling for Hjerte, Diabetes og Hormonsygdomme
Afdelingen for hjerte- og hormonsygdomme - Regionshosp. Nordjylland, Hjørring
Borne- og ungeafdelingen
Cardiology
Center for Klinisk Forskning Afdeling 202B
Department of Anesthesiology and Intensive Care
Department of Cardiology
Department of Intensive Care
Department of Pediatrics
Dept Cardiology
Hjertemedicinsk afd.

Clinical trials at this site (16)

Search interface

A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Not authorised

2022-502781-24-00 ASCVD - Atherosclerotic Cardiovascular Disease 11
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine when Given to Healthy Children 3 Month… Not authorised

2024-516635-27-00 Varicella 5
A study on the immune response and safety of an investigational chickenpox vaccine and a marketed measles, mumps and rubella vaccine when ad… Recruiting

2024-518840-18-00 Varicella 5 2025-12-10
Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) Recruiting

2023-509703-33-00 Septic Shock 6 2025-06-26
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
Comparing the Efficacy and Safety of Aspirin Alone versus Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (… Recruiting

2024-517229-18-00 Non-ST-Elevation Myocardial Infarction (NSTEMI) 11 2025-04-30
Goal directed fluid removal in critically ill patients with fluid overload Recruiting

2024-512186-14-00 Fluid overload/fluid accumulation 6 2020-08-24
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 ASCVD - Atherosclerotic Cardiovascular Disease 5 2024-06-05
Bicarbonate for the treatment of cardiac arrest Ended

2022-501304-10-00 In-hospital cardiac arrest 6 2023-02-06
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
Study on immunogenicity and safety of a meningococcal ACYW conjugate vaccine in healthy infants and toddlers Ended

2023-508177-85-00 Healthy volunteers (Meningococcal infection) 5 2024-03-12
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
A study to test the safety of MK-1654 and how well MK-1654 works in healthy infants Ended

2022-500350-42-01 Prevention of RSV 10 2022-11-07
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Ended

2022-500881-80-00 Chronic Heart Failure With Reduced Ejection Fraction 5 2021-10-29
Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) Ended

2024-515748-22-01 Myocardinal infarction 5 2018-12-01
DANHEART Ended

2024-514212-27-00 Heart failure 5